Anxiolytic- and antidepressant-like effects of the non-peptide vasopressin V 1b receptor antagonist, SSR149415, suggest an innovative approach for the treatment of stress-related disorders
Open accessThe DOI matches its Crossref record; 31 of the 31 references it cites were found in a registry or an index.
Abstract
The limbic localization of the arginine vasopressin V 1b receptor has prompted speculation as to a potential role of this receptor in the control of emotional processes. To investigate this possibility, we have studied the behavioral effects of SSR149415, the first selective and orally active non-peptide antagonist of vasopressin V 1b receptors, in a variety of classical (punished drinking, elevated plus-maze, and light/dark tests) and atypical (fear/anxiety defense test battery and social defeat-induced anxiety) rodent models of anxiety, and in two models of depression [forced swimming and chronic mild stress (CMS)]. When tested in classical tests of anxiety, SSR149415 produced anxiolytic-like activity at doses that ranged from 1 to 30 mg/kg (i.p. or p.o.), but the magnitude of these effects was overall less than that of the benzodiazepine anxiolytic diazepam, which was used as a positive control. In contrast, SSR149415 produced clear-cut anxiolytic-like activity in models involving traumatic stress exposure, such as the social defeat paradigm and the defense test battery (1–30 mg/kg, p.o.). In the forced swimming test, SSR149415 (10–30 mg/kg, p.o.) produced antidepressant-like effects in both normal and hypophysectomized rats. Moreover, in the CMS model in mice, repeated administration of SSR149415 (10 and 30 mg/kg, i.p.) for 39 days improved the degradation of the physical state, anxiety, despair, and the loss of coping behavior produced by stress. These findings point to a role for vasopressin in the modulation of emotional processes via the V 1b receptor, and suggest that its blockade may represent a novel avenue for the treatment of affective disorders.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Validation of open:closed arm entries in an elevated plus-maze as a measure of anxiety in the rat
Pellow, S., Chopin, P., File, S. E., & Briley, M. (1985) · Journal of Neuroscience Methods · doi:10.1016/0165-0270(85)90031-7 · Cited by 5,822
Depression: a new animal model sensitive to antidepressant treatments
PORSOLT, R. D., LE PICHON, M., & JALFRE, M. (1977) · Nature · doi:10.1038/266730a0 · Cited by 4,451
Neurocircuitry of stress: central control of the hypothalamo–pituitary–adrenocortical axis
Herman, J. P., & Cullinan, W. E. (1997) · Trends in Neurosciences · doi:10.1016/s0166-2236(96)10069-2 · Cited by 2,270
Chronic mild stress-induced anhedonia: A realistic animal model of depression
Willner, P., Muscat, R., & Papp, M. (1992) · Neuroscience & Biobehavioral Reviews · doi:10.1016/s0149-7634(05)80194-0 · Cited by 1,160
A simple and reliable conflict procedure for testing anti-anxiety agents
Vogel, J. R., Beer, B., & Clody, D. E. (1971) · Psychopharmacologia · doi:10.1007/bf00403989 · Cited by 841
Ethopharmacological analysis of rat behavior on the elevated plus-maze
Cruz, A. P. M., Frei, F., & Graeff, F. G. (1994) · Pharmacology Biochemistry and Behavior · doi:10.1016/0091-3057(94)90472-3 · Cited by 823
de Vries, G. J., & Buijs, R. M. (1983) · Brain Research · doi:10.1016/0006-8993(83)90855-7 · Cited by 565
Molecular cloning and expression of a rat Via arginine vasopressin receptor
Morel, A., O'Carroll, A.-M., Brownstein, M. J., & Lolaft, S. J. (1992) · Nature · doi:10.1038/356523a0 · Cited by 477
Animal models for the study of anti-anxiety agents: A review
Treit, D. (1985) · Neuroscience & Biobehavioral Reviews · doi:10.1016/0149-7634(85)90046-6 · Cited by 450
Miczek, K. A. (1979) · Psychopharmacology · doi:10.1007/bf00426664 · Cited by 397
Research works printed but not linked: 3
- D De Wied J Endocrinol 48, xlv–xlvi (1970).
- R Dantzer, R M Bluthe Crit Rev Neurobiol 6, 243–255 (1992).
- J Simiand, P E Keane, M C Barnouin, M Keane, P Soubrié, G Le Fur Fundam Clin Pharmacol 7, 413–427 (1993).
Cited by
Items 401–500 of 524
Searching for Biological Markers of Personality: Are There Neuroendocrine Markers of Anxiety?
Armario, A., & Nadal, R. A. (2013) · InTech eBooks · doi:10.5772/53925 · Cited by 3
Neuroendocrine functions, mood and quality of life
Mazza, M., & Mazza, S. (2007) · Springer eBooks · doi:10.1007/978-1-4020-5779-3_3 · Cited by 3
The hypothalamic vasopressin circuit drives lateralized endocrine signaling
Bakalkin, G. Y., Watanabe, H., Kobikov, Y., 李贵发, Nosova, O., Rich, K., Lindström, E., Sarkisyan, D., Hallberg, M., Ueta, Y., et al. (2026) · Neurobiology of Disease · doi:10.1016/j.nbd.2026.107340 · Cited by 2
Immune and Endocrine Function in Child and Adolescent Obsessive Compulsive Disorder
Murphy, T. K., & Yokum, K. (2011) · Springer eBooks · doi:10.1007/978-1-4419-7784-7_33 · Cited by 2
El futuro de la farmacoterapia antidepresiva
González-Ferreras, C. (2006) · Revista Colombiana de Psiquiatría · Cited by 2
Ising, M., Holsboer, F., Myhsok, M., & Müller‐Myhsok, B. (2025) · Pharmacopsychiatry · doi:10.1055/a-2508-5834 · Cited by 2
“Other clinical findings that support a close link between dex/CRH-test and complementary AVP/V1b-signaling include increased AVP expression in brains, particularly hypothalamic neurons, of depressed patients having committed suicide [19–21], and studies in healthy first-degree relatives of patients…”
Novel Targets for Drug Treatment in Psychiatry
Kurita, M., García‐Bea, A., & González‐Maeso, J. (2016) · Springer eBooks · doi:10.1007/978-1-4939-2528-5_30 · Cited by 2
Ślusarz, M. J. (2024) · Biopolymers · doi:10.1002/bip.23627 · Cited by 2
Social Stress Effects on Defensive Behavior and Anxiety
Pearson, B. L., Blanchard, D. C., & Blanchard, R. J. (2011) · Wiley eBooks · doi:10.1002/9781118083222.ch18 · Cited by 2
Green, J. J., Taylor, B. P., & Hollander, E. (2013) · Cambridge University Press eBooks · doi:10.1017/cbo9781139017855.024 · Cited by 2
Pharmakologie und klinische Bedeutung von Vasopressinantagonisten
Lemmens‐Gruber, R., & Kamyar, M.-R. (2008) · Der Internist · doi:10.1007/s00108-008-2017-z · Cited by 2
Role of vasopressin receptor in psychological and cognitive functions
Egashira, N., Mishima, K., Iwasaki, K., Nakanishi, H., Oishi, R., & Fujiwara, M. (2009) · Folia Pharmacologica Japonica · doi:10.1254/fpj.134.3 · Cited by 2
Dissecting a Model of Depressive-Related Phenotype and Antidepressant Effects in 129S2/SvPas Mice
Diaz, S. L., & Maroteaux, L. (2014) · Neuromethods · doi:10.1007/978-1-4939-2187-4_4 · Cited by 2
The modulatory effects of depression on pain perception: A review of animal model studies
Wang, N., Wei, X., Wang, J., & Luo, F. (2018) · Chinese Science Bulletin (Chinese Version) · doi:10.1360/n972017-01255 · Cited by 2
Kallman, M. J. (2015) · Springer eBooks · doi:10.1007/978-3-319-05392-9_31 · Cited by 2
Alexander, S. P. H., Mathie, A. A., & Peters, J. A. (2008) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0707753 · Cited by 2
Welt, T., Erhardt, A., Müller, M. B., Sillaber, I., & Keck, M. E. (2003) · Nervenheilkunde · doi:10.1055/s-0038-1626315 · Cited by 2
Zukunftsstrategien für die Entdeckung neuer Antidepressiva
Holsboer, F. (2008) · Springer eBooks · doi:10.1007/978-3-540-68748-1_9 · Cited by 2
Froestl, W. (2004) · CHIMIA International Journal for Chemistry · doi:10.2533/000942904777678280 · Cited by 2
Solubilisation and characterisation of G-protein-coupled receptors using styrene maleic acid polymer
Charlton, J. (2016) · University of Birmingham Institutional Research Archive (University of Birmingham) · Cited by 2
MacKay, J. C. (2016) · uO Research (University of Ottawa) · doi:10.20381/ruor-5621 · Cited by 2
Leske, O. (2009) · Dokumentenrepositorium der RUB (Ruhr University Bochum) · Cited by 2
Neuropeptide Receptors: Novel Therapeutic Targets for Depression and Anxiety Disorders
Chaki, S., & Kanuma, K. (2012) · Royal Society of Chemistry eBooks · doi:10.1039/9781849734943-00300 · Cited by 1
Vasopressin and oxytocin receptors in GtoPdb v.2025.3
Bichet, D. G., Wheatley, M., Verbalis, J. G., Soloff, M. S., Gal, C. S., O'Carroll, A.-M., Mouillac, B., Manning, M., Lolait, S. J., Knepper, M., et al. (2025) · IUPHAR/BPS Guide to Pharmacology CITE · doi:10.2218/gtopdb/f66/2025.3 · Cited by 1
Zhang, Y., Jin, Z., Yuan, Z., Chen, J., & Yang, X. (2026) · Buildings · doi:10.3390/buildings16030622 · Cited by 1
A study on evaluation of antidepressant effect of Imipramine adjunct with Ashwagandha and Bramhi
Maiti, T., Adhikari, A., & Panda, A. (2012) · International Journal of Ayurvedic Medicine · doi:10.47552/ijam.v3i1.155 · Cited by 1
Ordyan, N. E., Пивина, С. Г., Mironova, V. I., Rakitskaya, V. V., & Акулова, В. К. (2016) · Neuroscience and Behavioral Physiology · doi:10.1007/s11055-016-0276-z · Cited by 1
“Experimental data have been reported showing that intraventricular administration of vasopressin increases anxiety levels [24], while antagonists of its receptors have anxiolytic and antidepressant effects in rodents [17].”
München, L.-M.-U. (2013) · Cited by 1
Arioglu‐Inan, E., & Kayki‐Mutlu, G. (2021) · Elsevier eBooks · doi:10.1016/b978-0-12-820472-6.00162-6 · Cited by 1
Kallman, M. J. (2016) · Springer eBooks · doi:10.1007/978-3-642-27728-3_31-2 · Cited by 1
Taveau, C. (2014) · theses.fr (ABES) · doi:10.70675/ae70a073z3913z427azadb3z150d685f522f · Cited by 1
Vasopressin: The neglected target for stress modulation?
Dinan, T. G. (2005) · Stress and Health · doi:10.1002/smi.1054 · Cited by 1
Malan‐Müller, S. (2014) · SUNScholar (Stellenbosch University) · Cited by 1
Innovations in CNS drug discovery: differentiating strategies to treat depression
Beyer, C. E., & Hughes, Z. A. (2007) · Expert Opinion on Drug Discovery · doi:10.1517/17460441.2.10.1369 · Cited by 1
“SSR149415 was effective in rat FST and CMS and also showed anxiolytic-like effects in the gerbil social interaction and tonic immobility tests [68] .”
BackgroundBrouillard, C. (2015) · theses.fr (ABES) · doi:10.70675/c167b41fz6b52z423azaed1zb41a1fef1a26 · Cited by 1
New insights to the brain functions of prolyl oligopeptidase
Peltonen, I. (2012) · Helda - University of Helsinki Institutional Repository · Cited by 1
治療薬シリーズ(1)うつ病 2)神経ペプチド受容体:抗うつ薬創出の新しいターゲット
Chaki, S., & Okuyama, S. (2006) · Folia Pharmacologica Japonica · doi:10.1254/fpj.127.196 · Cited by 1
The Measurement and Investigation of Psychological Stress Sensitivity in Schizophrenia Risk
Grattan, R. E. (2017) · Otago University Research Archive (University of Otago) · Cited by 1
Jones, R. (2002) · Nature reviews. Neuroscience · doi:10.1038/nrn862 · Cited by 1
Capurro, V. (2011) · Archivio Istituzionale della Ricerca (Universita Degli Studi Di Milano) · doi:10.13130/capurro-valeria_phd2011-01-17 · Cited by 1
Choleris, E., Pfaff, D. W., & Kavaliers, M. (2013) · Cambridge University Press eBooks · doi:10.1017/cbo9781139017855.021 · Cited by 1
Suh, H., Liebermann, H. R., Jansen, L. T., Colburn, A. T., Adams, J. D., Seal, A., Butts, C. L., Kirkland, T. W., Melander, O., Vanhaecke, T., et al. (2020) · British Journal Of Nutrition · doi:10.1017/s0007114520004444 · Cited by 1
(2009) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2009.00501.x · Cited by 1
Impact of CBG deficiency on emotional and cognitive processes
de Medeiros, G. F. (2016) · theses.fr (ABES) · doi:10.70675/5068781bzb1fez4551z99eez04f240a93ed0 · Cited by 1
Mombereau, C. (2006) · OpenGrey (Institut de l'Information Scientifique et Technique) · Cited by 1
Barberis, C., & Mouillac, B. (2007) · Elsevier eBooks · doi:10.1016/b978-008055232-3.60354-x
Frank, E. (2006) · Electronic Theses of LMU Munich (Ludwig-Maximilians-Universität München) · doi:10.5282/edoc.6264
Gene-environment interplay of extreme anxiety-related behavior
Sotnikov, S. (2014) · Electronic Theses of LMU Munich (Ludwig-Maximilians-Universität München) · doi:10.5282/edoc.17113
Lysine vasopressin blocks the effect of chlorodiazepoxide in behavioral tests
de Almeida, R. N. (2008) · African Journal of Pharmacy and Pharmacology · doi:10.5897/ajpp.9000200
Identification and optimisation of novel sulfonamide, selective vasopressin V1B receptor antagonists
Baker, J. Α., Bingham, M. J., Blackburn-Munro, R. E., Cai, J., Craighead, M. W., Gilfillan, R. F., Goan, K., Jaap, D., Milne, R., Morphy, J. R., et al. (2011) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2011.04.104
Brown, M. M. (2004) · The Lancet · doi:10.1016/s0140-6736(04)15795-4
Bowen, M. T. (2014) · The Sydney eScholarship Repository (The University of Sydney)
Murgatroyd, C. (2005) · Electronic Theses of LMU Munich (Ludwig-Maximilians-Universität München) · doi:10.5282/edoc.3592
Jacobson, L. H. (2007) · edoc (University of Basel) · doi:10.5451/unibas-004290851
“In mice, deterioration of coat condition also appear to be a sensitive measure (Griebel et al. 2002; Santarelli et al. 2003).”
BackgroundNeurotransmitter und Modulatoren
Hevers, W., Lüddens, H., Schloss, P. D., Keck, M. E., Landgraf, R., Rupprecht, R., & Lutz, B. (2008) · Springer eBooks · doi:10.1007/978-3-540-68748-1_10
Characterization of short-term synaptic plasticity at excitatory synapses to the supraoptic nucleus
Quinlan, M. E. (2006) · Memorial University Research Repository (Memorial University)
Zimmermann-Peruzatto, J. M. (2015) · Americanae (AECID Library)
Benton, C. S. (2011) · Carolina Digital Repository (University of North Carolina at Chapel Hill) · doi:10.17615/1143-ay27
The Hypothalamic–Pituitary–Adrenal Axis and Related Brain Stress-Response Systems and Heroin
Zhou, Y., Briggs, H., & Kreek, M. J. (2016) · Elsevier eBooks · doi:10.1016/b978-0-12-800213-1.00094-8
de Médecine, F., Doctorale, É., & Biologie, C. (2003)
Yoshida, H. (2009) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2009.00501_64.x
The role of central vasopressin V2 receptors in cardiovascular homeostasis
Milutinović‐Smiljanić, S. (2013) · doi:10.2298/bg20130620milutinovicsmiljanic
Rotzinger, S. (2013) · Elsevier eBooks · doi:10.1016/b978-0-12-385095-9.00254-2
Animal models of depressive illness and sickness behavior
Dunn, A. J. (2010) · Cambridge University Press eBooks · doi:10.1017/cbo9780511780868.013
The role of the vasopressin 1b receptor in the regulation of sensorimotor gating
Dhakar, M. B. (2011) · OhioLink ETD Center (Ohio Library and Information Network)
Vasopressin and Social Behavior in Richardson's Ground Squirrels
Freeman, A. R. (2016) · OhioLink ETD Center (Ohio Library and Information Network)
Kolk, K. S., Karges, W., & Clusmann, H. (2015) · RWTH Publications (RWTH Aachen)
Frantz, S. (2002) · Nature Reviews Drug Discovery · doi:10.1038/nrd887
The Effect of High-Fructose Corn syrup on Ethanol Taking, Seeking, and Palatability in Rats
Ayoub, S. M. (2018) · The Atrium (University of Guelph)
Erichsen, C. L. (2018) · Boloka Institutional Repository (North-west University)
Microglia morphology and susceptibility to depression - impact of sex differences
Gaspar, A. R. (2020) · Portuguese National Funding Agency for Science, Research and Technology (RCAAP Project by FCT)
Keck, M. E., & Landgraf, R. (2011) · Springer eBooks · doi:10.1007/978-3-642-19844-1_19
(2005) · Wiley eBooks · doi:10.1002/9780470713648.refs
Kallman, M. J. (2015) · Springer eBooks · doi:10.1007/978-3-642-27728-3_31-1
Alexander, S. P. H., Mathie, A. A., & Peters, J. A. (2006) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0706549
Mucke, H. A. (2014) · Pharmaceutical Patent Analyst · doi:10.4155/ppa.14.1
Prakash, P. (2005) · Carleton University's Institutional Repository (MacOdrum Library, Carleton University) · doi:10.22215/etd/2005-08407
Barberis, C., & Mouillac, B. (2007) · Elsevier eBooks · doi:10.1016/b978-008055232-3.60356-3
(2022) · Society for Neuroscience eBooks · doi:10.1523/hon.012005
Research Progress on the Structure and Function of Arginine Vasopressin and Its Receptor
姚, 菊. (2025) · Hans Journal of Biomedicine · doi:10.12677/hjbm.2025.152040
A Novel Strategy for the Synthesis of N-Alkylated Oxindoles
Anh, D. T., Baecker, D., Thien, N. D., Ngoc, H. K., & Nam, N. (2025) · Synlett · doi:10.1055/s-0043-1775460
Gao, S.-F., Zhang, Q.-M., Cheng, G., Tang, C.-C., Wan, W., & Wang, L. (2025) · Tetrahedron Letters · doi:10.1016/j.tetlet.2025.155644
Off-label and investigational drugs in the treatment of alcohol use disorder: A critical review
Fischler, P. V. (2024) · Zenodo (CERN European Organization for Nuclear Research) · doi:10.5281/zenodo.13940804
Ramos, A. T. (2012) · Americanae (AECID Library)
Epigenetische Regulation und mRNA-Expression von Vasopressin während des Alkoholentzugs
Luber, K. (2010) · OPUS FAU (Kooperativer Bibliotheksverbund Berlin-Brandenburg (KOBV), on behalf of the Universitätsbibliothek Erlangen-Nürnberg)
Influences of social stress in the rewarding effects of mdma and alcohol
García Pardo, M. P. (2015) · Repository of Digital Objects for Teaching Research and Culture (University of Valencia)
Schorscher-Petcu, A. (2011) · eScholarship@McGill (McGill) · doi:10.82308/18370
Garcia, C. R. L. (2013) · Americanae (AECID Library)
Influência do sistema endocanabinóide sobre o sickness behavior induzidos pela endotoxemia em ratos
de Paiva, V. N. (2013) · Americanae (AECID Library)
Chronic social defeat stress as a depression model: Glucocorticoids implication
Nunes, Y. C. (2019) · LA Referencia (Red Federada de Repositorios Institucionales de Publicaciones Científicas)
Rafiei, D. (2022) · TSpace (University of Toronto)
Behavioural characterization of mannoside acetylglucosaminyltransferase 5 (Mgat5) deficient mice
Soleimani, L. (2006) · TSpace (University of Toronto)
A symmetric systemic challenge elicits a right‐biased response mediated by vasopressin signaling
Watanabe, H., Kobikov, Y., Mohamed, S. Y., Rich, K., Sarkisyan, D., Nosova, O., Grönbladh, A., Hallberg, M., Schouenborg, J., Bakalkin, G. Y., et al. (2026) · Journal of Neuroendocrinology · doi:10.1111/jne.70257
Ibargüen-Vargas, Y. (2008) · theses.fr (ABES) · doi:10.70675/2d73c017z46fcz4c35z8397zb504072e069a
Hache, G. (2012) · theses.fr (ABES) · doi:10.70675/84bd0279zb039z410cz8182z7334f593826d
“stress) qui conserve l’exposition des animaux à divers évènements stressant légers, mais inclue une séquence aléatoire des stresseurs appliqués, rendant la prédictibilité du protocole impossible à anticiper pour l’animal (Griebel et al., 2002; Surget et al., 2008).”
Metadata
- Authors
- Griebel, G., Simiand, J., Serradeil-Le Gal, C., Wagnon, J., Pascal, M., Scatton, B., Maffrand, J.-P., & Soubrié, P.
- Affiliations
- Sanofi (France) (FR)
- Sanofi–Synthelabo Recherche, Avenue P. V.-Couturier, 92220 Bagneux, France; Sanofi–Synthelabo Recherche, Route d'Espagne, 31100 Toulouse, France; and Sanofi–Synthelabo Recherche, Rue du Professeur Blayac, 34000 Montpellier, France
- Venue
- Proceedings of the National Academy of Sciences
- Publisher
- National Academy of Sciences
- Published
- 2002-04-16
- Volume
- 99
- Issue
- 9
- Pages
- 6370-6375
- ISSN
- 0027-8424 (ISSN-L)
- 1091-6490
- PMC
- PMC122955
- OpenAlex
- W2003547326
- Cited by
- 471
- References
- 31
- Citations by year
- 2026: 6 · 2025: 7 · 2024: 6 · 2023: 6 · 2022: 8 · 2021: 12 · 2020: 14 · 2019: 10 · 2018: 15 · 2017: 8 · 2016: 20 · 2015: 18 · 2014: 29 · 2013: 16 · 2012: 21
- FWCI
- 10.11
- Type
- journal article
- Language
- en
- Open access
- green
- europepmc.org
- Locations
- Proceedings of the National Academy of Sciences (publishedVersion)
- Europe PMC (PubMed Central) (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neuropeptides and Animal Physiology
- Life Sciences › Neuroscience › Endocrine and Autonomic Systems › Neuroendocrine regulation and behavior
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neurotransmitter Receptor Influence on Behavior
- Keywords
- non-peptide antagonists, anxiolytic effects, antidepressant effects, anxiety, depression, chronic mild stress, social defeat, traumatic stress, emotional processing, hypophysectomy, mood disorders
- MeSH terms
- Animals, Antidepressive Agents, Antidepressive Agents, Tricyclic, Anxiety, Behavior, Animal, Depression, Feeding Behavior, Fluoxetine, Imipramine, Indoles, Kinetics, Male, Mice, Inbred BALB C, Pyrrolidines, Stress, Physiological, Stress, Psychological, Time Factors, Anti-Anxiety Agents, Rats, Sprague-Dawley, Rats, Wistar, Risk Assessment, Antidepressive Agents, Second-Generation, Mice, Rats, Antidiuretic Hormone Receptor Antagonists
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.